Regulatory changes that insert British processes in place of the EU’s for in vitro diagnostic medical devices (IVDs) accessing the market in Great Britain are summarized in new guidance issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA) on 17 July.
The guidance, governing the supply of IVDs medical devices in England, Scotland and Wales, explains the main features of part IV of the medical devices statutory instrument, the UK...